Literature DB >> 7571841

Universal hepatitis B immunization: the British Columbia experience.

A Bell1.   

Abstract

Between 1980 and 1992 there was a 70-fold increase in reported hepatitis B cases in British Columbia (BC), to a rate of 32 per 100,000 population, more than three times the national average of 10 per 100,000. In BC, this disease is one of young adults--less than 5% of reported cases occur under the age of 15 years. While Canada remains an area of low endemicity where transmission is mostly sexual or as a result of lifestyle choices, programmes of targeted immunization of certain high-risk groups (neonates of infected mothers, household and sexual contacts of acute cases and selected healthcare workers) begun in the mid-1980s have failed to reduce the increasing rate of reported infection. In September 1992, an expanded programme of hepatitis B immunization was implemented in BC. The programme has two main components: universal immunization of a cohort of pre-adolescent children in schools and broadened targeted immunization of groups at known elevated risk for transmission. The school-based programme involves provision of a three-dose series by public health nurses to all children in grade 6 (age 11 years) for whom parental consent is given. During the 1992-1993 school year, more than 42,000 grade 6 students were eligible for hepatitis B vaccine and the three-dose series was completed by 91% of students throughout the province.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7571841     DOI: 10.1016/0264-410x(95)80061-h

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Relation between experimental and non-experimental study designs. HB vaccines: a case study.

Authors:  T Jefferson; V Demicheli
Journal:  J Epidemiol Community Health       Date:  1999-01       Impact factor: 3.710

Review 2.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

3.  Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention.

Authors:  K H Seal; K C Ochoa; J A Hahn; J P Tulsky; B R Edlin; A R Moss
Journal:  West J Med       Date:  2000-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.